{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:31:06Z","timestamp":1793345466530,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2018R1A5A2023879"],"award-info":[{"award-number":["NRF-2018R1A5A2023879"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2022R1A2C1092088"],"award-info":[{"award-number":["NRF-2022R1A2C1092088"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cancer-associated fibroblasts (CAFs), the predominant stromal cells in the tumor microenvironment (TME), play a critical role in the progression of solid tumors, including oral squamous cell carcinoma (OSCC). However, the molecular mechanisms by which OSCC-derived factors mediate CAF differentiation remain incompletely understood. This study investigates the role of the C-X-C motif chemokine ligand 1 (CXCL1), secreted by OSCC cells, in promoting CAF differentiation and its downstream impact on tumor progression. Gingival fibroblasts (GFs) were treated with conditioned medium (CM) from various OSCC cell lines to assess their potential to induce CAF differentiation. Proteomic analysis using liquid chromatography\u2013mass spectrometry identified CXCL1 as a key factor highly secreted in SCC25-derived CM, which exhibited the strongest capacity to induce CAF differentiation. CXCL1 synergistically enhanced TGF-\u03b21-induced differentiation of GFs into \u03b1-smooth muscle actin (\u03b1SMA)- and vimentin-expressing CAFs by approximately 1.5-fold, confirming its co-stimulatory function. Conversely, silencing its receptor CXCR2 reduced CAF marker expression by over 50%, indicating a strong inhibitory effect on CAF differentiation. In vivo, co-injection of SCC25 cells with GFs significantly promoted tumor growth and stromal CAF marker expression, whereas CXCR2 knockdown in GFs led to a\u2009~\u200940% reduction in tumor volume and reduced \u03b1SMA\/vimentin-positive CAFs. These findings establish CXCL1 as a pivotal mediator of CAF differentiation through CXCR2-dependent signaling, and highlight that the CXCL1\u2013CXCR2 axis is a promising therapeutic target for modulating stromal\u2013tumor interactions in OSCC.<\/jats:p>","DOI":"10.1186\/s43556-025-00281-8","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T23:01:46Z","timestamp":1749510106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["C-X-C motif chemokine ligand 1 derived from oral squamous cell carcinoma promotes cancer-associated fibroblast differentiation and tumor growth"],"prefix":"10.1186","volume":"6","author":[{"given":"Soon Chul","family":"Heo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-hye","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Ram","family":"Keum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeo Gyun","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Yeol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2962-9553","authenticated-orcid":false,"given":"Hyung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"281_CR1","doi-asserted-by":"publisher","unstructured":"Lala M, Chirovsky D, Cheng JD, Mayawala K. Clinical outcomes with therapies for previously treated recurrent\/metastatic head-and-neck squamous cell carcinoma (R\/M HNSCC): A systematic literature review. Oral Oncol. 2018;84:108\u201320.\u00a0https:\/\/doi.org\/10.1016\/j.oraloncology.2018.07.005","DOI":"10.1016\/j.oraloncology.2018.07.005"},{"key":"281_CR2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.\u00a0https:\/\/doi.org\/10.3322\/caac.21551","DOI":"10.3322\/caac.21551"},{"key":"281_CR3","doi-asserted-by":"publisher","unstructured":"Kim H, Lee SM, Ahn KM. The epidemiological and histopathological factors for delayed local recurrence in oral squamous cell carcinoma. Maxillofac Plast Reconstr Surg. 2024;46(1):38.\u00a0https:\/\/doi.org\/10.1186\/s40902-024-00443-8","DOI":"10.1186\/s40902-024-00443-8"},{"key":"281_CR4","doi-asserted-by":"publisher","unstructured":"Linsen SS, Gellrich NC, Kruskemper G. Age- and localization-dependent functional and psychosocial impairments and health related quality of life six months after OSCC therapy. Oral Oncol. 2018;81:61\u20138. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.04.011","DOI":"10.1016\/j.oraloncology.2018.04.011"},{"key":"281_CR5","doi-asserted-by":"publisher","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337. https:\/\/doi.org\/10.1038\/nm.3394","DOI":"10.1038\/nm.3394"},{"key":"281_CR6","doi-asserted-by":"publisher","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell. 2005;121(3):335\u201348.\u00a0https:\/\/doi.org\/10.1016\/j.cell.2005.02.034","DOI":"10.1016\/j.cell.2005.02.034"},{"key":"281_CR7","doi-asserted-by":"publisher","unstructured":"Lv K, He T. Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets. Mol Biomed. 2024;5(1):70. https:\/\/doi.org\/10.1186\/s43556-024-00233-8","DOI":"10.1186\/s43556-024-00233-8"},{"key":"281_CR8","doi-asserted-by":"publisher","unstructured":"Liu L, Liu L, Yao HH, Zhu ZQ, Ning ZL, Huang Q. Stromal Myofibroblasts Are Associated with Poor Prognosis in Solid Cancers: A Meta-Analysis of Published Studies. PLoS One. 2016;11(7):e0159947. https:\/\/doi.org\/10.1371\/journal.pone.0159947","DOI":"10.1371\/journal.pone.0159947"},{"key":"281_CR9","doi-asserted-by":"publisher","unstructured":"Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet. 2015;47(4):320\u20139. https:\/\/doi.org\/10.1038\/ng.3225","DOI":"10.1038\/ng.3225"},{"key":"281_CR10","doi-asserted-by":"publisher","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.73","DOI":"10.1038\/nrc.2016.73"},{"key":"281_CR11","doi-asserted-by":"publisher","unstructured":"Kahounova Z, Kurfurstova D, Bouchal J, Kharaishvili G, Navratil J, Remsik J et al. The fibroblast surface markers FAP, anti-fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial-to-mesenchymal transition. Cytometry A. 2018;93(9):941\u201351. https:\/\/doi.org\/10.1002\/cyto.a.23101","DOI":"10.1002\/cyto.a.23101"},{"key":"281_CR12","doi-asserted-by":"publisher","unstructured":"Calvo F, Ege N, Grande-Garcia A, Hooper S, Jenkins RP, Chaudhry SI et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15(6):637\u201346.\u00a0https:\/\/doi.org\/10.1038\/ncb2756","DOI":"10.1038\/ncb2756"},{"key":"281_CR13","doi-asserted-by":"publisher","unstructured":"Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150(1):165\u201378.\u00a0https:\/\/doi.org\/10.1016\/j.cell.2012.04.042","DOI":"10.1016\/j.cell.2012.04.042"},{"key":"281_CR14","doi-asserted-by":"publisher","unstructured":"Wei LY, Lee JJ, Yeh CY, Yang CJ, Kok SH, Ko JY et al. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1. Oral Oncol. 2019;88:115\u201323.\u00a0https:\/\/doi.org\/10.1016\/j.oraloncology.2018.11.002","DOI":"10.1016\/j.oraloncology.2018.11.002"},{"key":"281_CR15","doi-asserted-by":"publisher","unstructured":"Zhang WL, Fan HY, Chen BJ, Wang HF, Pang X, Li M et al. Cancer-associated fibroblasts-derived CXCL1 activates DEC2-mediated dormancy in oral squamous cell carcinoma. Heliyon. 2024;10(20):e39133. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39133","DOI":"10.1016\/j.heliyon.2024.e39133"},{"key":"281_CR16","doi-asserted-by":"publisher","unstructured":"Zhang S, Dong Y, Zhao S, Bi F, Xuan M, Zhu G et al. CXCL1 promoted the migration and invasion abilities of oral cancer cells and might serve as a promising marker of prognosis in tongue cancer. J Oral Pathol Med. 2023;52(7):583\u201392. https:\/\/doi.org\/10.1111\/jop.13418","DOI":"10.1111\/jop.13418"},{"key":"281_CR17","doi-asserted-by":"publisher","unstructured":"Miyake M, Furuya H, Onishi S, Hokutan K, Anai S, Chan O et al. Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth. Theranostics. 2019;9(3):853\u201367. https:\/\/doi.org\/10.7150\/thno.29553","DOI":"10.7150\/thno.29553"},{"issue":"12","key":"281_CR18","first-page":"6979","volume":"35","author":"A Spaks","year":"2015","unstructured":"Spaks A, Jaunalksne I, Spaka I, Chudasama D, Pirtnieks A, Krievins D. Diagnostic Value of Circulating CXC Chemokines in Non-small Cell Lung Cancer. Anticancer Res. 2015;35(12):6979\u201383.","journal-title":"Anticancer Res"},{"key":"281_CR19","doi-asserted-by":"publisher","unstructured":"Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol. 2004;172(5):2853\u201360.\u00a0https:\/\/doi.org\/10.4049\/jimmunol.172.5.2853","DOI":"10.4049\/jimmunol.172.5.2853"},{"key":"281_CR20","doi-asserted-by":"publisher","unstructured":"Sharma B, Nawandar DM, Nannuru KC, Varney ML, Singh RK. Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis. Mol Cancer Ther. 2013;12(5):799\u2013808.https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0529","DOI":"10.1158\/1535-7163.MCT-12-0529"},{"key":"281_CR21","doi-asserted-by":"publisher","unstructured":"Huang W, Jiang M, Lin Y, Qi Y, Li B. Crosstalk between cancer cells and macrophages promotes OSCC cell migration and invasion through a CXCL1\/EGF positive feedback loop. Discov Oncol. 2024;15(1):145. https:\/\/doi.org\/10.1007\/s12672-024-00972-8","DOI":"10.1007\/s12672-024-00972-8"},{"key":"281_CR22","doi-asserted-by":"publisher","unstructured":"Lin LH, Lin JS, Yang CC, Cheng HW, Chang KW, Liu CJ. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma. Int J Mol Sci. 2020;21(7).https:\/\/doi.org\/10.3390\/ijms21072360","DOI":"10.3390\/ijms21072360"},{"key":"281_CR23","doi-asserted-by":"publisher","unstructured":"Wu F, Yang J, Liu J, Wang Y, Mu J, Zeng Q et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct Target Ther. 2021;6(1):218.\u00a0https:\/\/doi.org\/10.1038\/s41392-021-00641-0","DOI":"10.1038\/s41392-021-00641-0"},{"key":"281_CR24","doi-asserted-by":"publisher","unstructured":"Ahuja SK, Murphy PM. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem. 1996;271(34):20545\u201350.\u00a0https:\/\/doi.org\/10.1074\/jbc.271.34.20545","DOI":"10.1074\/jbc.271.34.20545"},{"key":"281_CR25","doi-asserted-by":"publisher","unstructured":"Kim EK, Moon S, Kim DK, Zhang X, Kim J. CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma. PLoS One. 2018;13(1):e0188847. https:\/\/doi.org\/10.1371\/journal.pone.0188847","DOI":"10.1371\/journal.pone.0188847"},{"key":"281_CR26","doi-asserted-by":"publisher","unstructured":"Zheng S, He S, Liang Y, Tan Y, Liu Q, Liu T et al. Understanding PI3K\/Akt\/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example. Mol Biomed. 2024;5(1):13.\u00a0https:\/\/doi.org\/10.1186\/s43556-024-00176-0","DOI":"10.1186\/s43556-024-00176-0"},{"key":"281_CR27","doi-asserted-by":"publisher","unstructured":"Wang J, Jiang C, Li N, Wang F, Xu Y, Shen Z et al. The circEPSTI1\/mir-942\u20135p\/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K\/Akt\/mTOR pathway. Cell Death Dis. 2020;11(8):682. https:\/\/doi.org\/10.1038\/s41419-020-02851-w","DOI":"10.1038\/s41419-020-02851-w"},{"key":"281_CR28","doi-asserted-by":"publisher","unstructured":"Zhang X, Dong Y, Zhao M, Ding L, Yang X, Jing Y et al. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system. Theranostics. 2020;10(26):12044\u201359.\u00a0https:\/\/doi.org\/10.7150\/thno.47901","DOI":"10.7150\/thno.47901"},{"key":"281_CR29","doi-asserted-by":"publisher","unstructured":"Fang WB, Mafuvadze B, Yao M, Zou A, Portsche M, Cheng N. TGF-beta Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2\/3 and Suppression of HGF\/c-Met Signaling Mechanisms. PLoS One. 2015;10(8):e0135063.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0135063","DOI":"10.1371\/journal.pone.0135063"},{"key":"281_CR30","doi-asserted-by":"publisher","unstructured":"Fang L, Che Y, Zhang C, Huang J, Lei Y, Lu Z et al. LAMC1 upregulation via TGFbeta induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-kappaB-CXCL1-STAT3. Mol Oncol. 2021;15(11):3125\u201346. https:\/\/doi.org\/10.1002\/1878-0261.13053","DOI":"10.1002\/1878-0261.13053"},{"key":"281_CR31","doi-asserted-by":"publisher","unstructured":"Curtis M, Kenny HA, Ashcroft B, Mukherjee A, Johnson A, Zhang Y et al. Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis. Cell Metab. 2019;29(1):141\u201355 e9. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.007","DOI":"10.1016\/j.cmet.2018.08.007"},{"key":"281_CR32","doi-asserted-by":"publisher","unstructured":"Jahangiri B, Khalaj-Kondori M, Asadollahi E, Sadeghizadeh M. Cancer-associated fibroblasts enhance cell proliferation and metastasis of colorectal cancer SW480 cells by provoking long noncoding RNA UCA1. J Cell Commun Signal. 2019;13(1):53\u201364.\u00a0https:\/\/doi.org\/10.1007\/s12079-018-0471-5","DOI":"10.1007\/s12079-018-0471-5"},{"key":"281_CR33","doi-asserted-by":"publisher","unstructured":"Wheeler SE, Shi H, Lin F, Dasari S, Bednash J, Thorne S et al. Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models. Head Neck. 2014;36(3):385\u201392.\u00a0https:\/\/doi.org\/10.1002\/hed.23312","DOI":"10.1002\/hed.23312"},{"key":"281_CR34","doi-asserted-by":"publisher","unstructured":"Qin X, Yan M, Wang X, Xu Q, Wang X, Zhu X et al. Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway. Theranostics. 2018;8(4):921\u201340. https:\/\/doi.org\/10.7150\/thno.22182","DOI":"10.7150\/thno.22182"},{"key":"281_CR35","doi-asserted-by":"publisher","unstructured":"Bae JY, Kim EK, Yang DH, Zhang X, Park YJ, Lee DY et al. Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1alpha induces cancer progression. Neoplasia. 2014;16(11):928\u201338.\u00a0https:\/\/doi.org\/10.1016\/j.neo.2014.09.003","DOI":"10.1016\/j.neo.2014.09.003"},{"key":"281_CR36","doi-asserted-by":"publisher","unstructured":"Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25(6):735\u201347. https:\/\/doi.org\/10.1016\/j.ccr.2014.04.021","DOI":"10.1016\/j.ccr.2014.04.021"},{"key":"281_CR37","doi-asserted-by":"publisher","unstructured":"Ohlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396. https:\/\/doi.org\/10.1084\/jem.20162024","DOI":"10.1084\/jem.20162024"},{"key":"281_CR38","doi-asserted-by":"publisher","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA et al. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts. Cancer Discov. 2019;9(8):1102\u201323.\u00a0https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0094","DOI":"10.1158\/2159-8290.CD-19-0094"},{"key":"281_CR39","doi-asserted-by":"publisher","unstructured":"Shintani S, Ishikawa T, Nonaka T, Li C, Nakashiro K, Wong DT et al. Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer. Oncology. 2004;66(4):316\u201322. https:\/\/doi.org\/10.1159\/000078333","DOI":"10.1159\/000078333"},{"key":"281_CR40","doi-asserted-by":"publisher","unstructured":"Reyimu A, Chen Y, Song X, Zhou W, Dai J, Jiang F. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis. World J Surg Oncol. 2021;19(1):240. https:\/\/doi.org\/10.1186\/s12957-021-02360-w","DOI":"10.1186\/s12957-021-02360-w"},{"key":"281_CR41","doi-asserted-by":"publisher","unstructured":"Yang B, Dong K, Guo P, Guo P, Jie G, Zhang G et al. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis. J Comput Biol. 2020;27(1):40\u201354. https:\/\/doi.org\/10.1089\/cmb.2019.0211","DOI":"10.1089\/cmb.2019.0211"},{"key":"281_CR42","doi-asserted-by":"publisher","unstructured":"Sun W, Qiu Z, Huang W, Cao M. Gene expression profiles and protein\u2011protein interaction networks during tongue carcinogenesis in the tumor microenvironment. Mol Med Rep. 2018;17(1):165\u201371. https:\/\/doi.org\/10.3892\/mmr.2017.7843","DOI":"10.3892\/mmr.2017.7843"},{"key":"281_CR43","doi-asserted-by":"publisher","unstructured":"Brondum L, Eriksen JG, Singers Sorensen B, Mortensen LS, Toustrup K, Overgaard J et al. Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients. Clin Transl Radiat Oncol. 2017;2:46\u201352.https:\/\/doi.org\/10.1016\/j.ctro.2017.01.001","DOI":"10.1016\/j.ctro.2017.01.001"},{"key":"281_CR44","doi-asserted-by":"publisher","unstructured":"Dufies M, Grytsai O, Ronco C, Camara O, Ambrosetti D, Hagege A et al. New CXCR1\/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments. Theranostics. 2019;9(18):5332\u201346.\u00a0https:\/\/doi.org\/10.7150\/thno.34681","DOI":"10.7150\/thno.34681"},{"key":"281_CR45","doi-asserted-by":"publisher","unstructured":"Ye MY, Chen MY, Chang YH, Huang JS, Huang TT, Wong TY et al. Growth-regulated oncogene-alpha from oral submucous fibrosis fibroblasts promotes malignant transformation of oral precancerous cells. J Oral Pathol Med. 2018;47(9):880\u20136.https:\/\/doi.org\/10.1111\/jop.12768","DOI":"10.1111\/jop.12768"},{"key":"281_CR46","doi-asserted-by":"publisher","unstructured":"Hughes CE, Nibbs RJB. A guide to chemokines and their receptors. FEBS J. 2018;285(16):2944\u201371. https:\/\/doi.org\/10.1111\/febs.14466","DOI":"10.1111\/febs.14466"},{"key":"281_CR47","doi-asserted-by":"publisher","unstructured":"White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA et al. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem. 1998;273(17):10095\u20138.https:\/\/doi.org\/10.1074\/jbc.273.17.10095","DOI":"10.1074\/jbc.273.17.10095"},{"key":"281_CR48","doi-asserted-by":"publisher","unstructured":"Romanini J, Mielcke TR, Leal PC, Figueiredo CP, Calixto JB, Morrone FB et al. The role of CXCR2 chemokine receptors in the oral squamous cell carcinoma. Invest New Drugs. 2012;30(4):1371\u20138. https:\/\/doi.org\/10.1007\/s10637-011-9701-x","DOI":"10.1007\/s10637-011-9701-x"},{"key":"281_CR49","doi-asserted-by":"publisher","unstructured":"Sueoka H, Hirano T, Uda Y, Iimuro Y, Yamanaka J, Fujimoto J. Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma. Surgery. 2014;155(4):640\u20139.\u00a0https:\/\/doi.org\/10.1016\/j.surg.2013.12.037","DOI":"10.1016\/j.surg.2013.12.037"},{"key":"281_CR50","doi-asserted-by":"publisher","unstructured":"Ning Y, Labonte MJ, Zhang W, Bohanes PO, Gerger A, Yang D et al. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Mol Cancer Ther. 2012;11(6):1353\u201364. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0915","DOI":"10.1158\/1535-7163.MCT-11-0915"},{"key":"281_CR51","doi-asserted-by":"publisher","unstructured":"Korbecki J, Bosiacki M, Barczak K, Lagocka R, Chlubek D, Baranowska-Bosiacka I. The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers. Cells. 2023;12(10). https:\/\/doi.org\/10.3390\/cells12101406","DOI":"10.3390\/cells12101406"},{"key":"281_CR52","doi-asserted-by":"publisher","unstructured":"Polizzi A, Santonocito S, Distefano A, De Pasquale R, Alibrandi A, Alanazi AM et al. Analysis of oral lichen planus severity on micro-RNA linked with malignant transformation risks. Oral Dis. 2024;30(5):2918\u201328.https:\/\/doi.org\/10.1111\/odi.14758","DOI":"10.1111\/odi.14758"},{"key":"281_CR53","doi-asserted-by":"publisher","unstructured":"Polizzi A, Tartaglia GM, Santonocito S, Alibrandi A, Verzi AE, Isola G. Impact of Topical Fluocinonide on Oral Lichen Planus Evolution: Randomized Controlled Clinical Trial. Oral Dis. 2025;31(2):510\u201321.https:\/\/doi.org\/10.1111\/odi.15156","DOI":"10.1111\/odi.15156"},{"key":"281_CR54","doi-asserted-by":"publisher","unstructured":"Zhang G, Wang Q, Qi X, Yang H, Su X, Yang M et al. OShnscc: a novel user-friendly online survival analysis tool for head and neck squamous cell carcinoma based on RNA expression profiles and long-term survival information. J Zhejiang Univ Sci B. 2022;23(3):249\u201357.\u00a0https:\/\/doi.org\/10.1631\/jzus.B2100512","DOI":"10.1631\/jzus.B2100512"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00281-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00281-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00281-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T23:01:47Z","timestamp":1749510107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00281-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["281"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00281-8","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"22 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animals were treated and maintained in accordance with the Principles of Laboratory Animal Care, and all experiments were performed using protocols approved by the Pusan National University Institutional Animal Use and Care Committee (PNU\u20102023\u20100271).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all participants\u00a0included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}